2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer


Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this program brings together a distinguished team of thought leaders in genitourinary cancers to present the latest strategies for managing localized and advanced bladder, kidney, and prostate cancers.

With rapid advances in systemic therapies, surgical techniques, and radiation technologies, clinicians are navigating an increasingly complex treatment landscape. The rapid entry of novel agents into the non-muscle invasive bladder cancer space is creating new therapeutic decision points. At the same time, advances in radiation oncology technologies and techniques continue to refine precision and efficacy. This CME program focuses on how to effectively integrate these innovations into everyday practice.

Through expert-led lectures, panel discussions, and case-based sessions, participants will gain practical insights they can apply directly in the clinical trenches.

PROGRAM DATE: Thursday, October 23, 2025

TIMES: 
5:45–7:00 pm EST Check-In and Reception
(Buffet opens at 6:30)
7:00–9:00 pm EST CME & Dinner

LOCATION: 

Philadelphia Marriott Old City 
One Dock Street 
Philadelphia, PA 19106

Registration:   https://www.eeds.com/live/467880

PROGRAM DIRECTORS

Alexander Kutikov, MD, FAC
Associate Professor, 
Chair and Professor, Department of Urology
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase – Temple Urologic Institute Provider
Fox Chase Cancer Center 

 

Fern M. Anari, MD
Assistant Professor, Department of Hematology/Oncology
Fox Chase Cancer Center


LEARNING OBJCTIVES:

  • Explain emerging systemic therapies for bladder, kidney, and prostate cancer
  • Highlight the rapid entry of novel agents into the non-muscle invasive bladder cancer treatment space
  • Discuss the newest data and evolving approaches in radiation oncology for localized and advanced genitourinary malignancies

INTENDED AUDIENCE: This program is designed for urologists; medical, radiation and surgical oncologists; radiologists; primary care physicians; fellows/residents/students; nurses; nurse practitioners; advanced practice providers; and all healthcare professionals involved in the care of patients with bladder, kidney, or prostate cancer.

ACCREDITATION STATEMENT:  The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

DESIGNATION STATEMENT: The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

INQUIRIES: Lucía Tono, PhD, MEd 215-728-3797 
Lucia.Tono-Ramirez@tuhs.temple.edu

EXHIBITOR INFORMATION: Contact Lisa Bailey to learn about opportunities to exhibit at this event at at 215-872-5846 or Lisa.Bailey@fccc.edu.


Published

September 25, 2025

Expires

September 25, 2030